CARCINOEMBRYONAL ANTIGEN IDIOTYPE VACCINE
CARCINOEMBRYONAL ANTIGEN IDIOTYPE VACCINE
批准号:
3493386
负责人:
HANS J HANSEN
金额:
$5.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-05-25 至 1993-11-24
中文摘要
描述:(改编自申请者摘要)癌症患者
通常对肿瘤细胞上表达的抗原具有耐受性。
触发患者对肿瘤相关的主动免疫反应
抗原代表了癌症最有希望的前景之一。
心理治疗。在这个项目中,研究人员提出了一项临床前研究
触发主动免疫反应的抗独特型方法
对CEA的指控。某些抗独特型抗体针对
针对特定抗原的抗体的可变区可以模仿
(即,带有该抗原的内部图像)。在几个实验中
系统,用抗独特型抗体免疫可引起特异性
免疫代替原始抗原的免疫力。用抗-DNA免疫
独特型抗体作为替代抗原是一种很有前途的方法
触发对耐受抗原的免疫,如肿瘤抗原。他们有
已产生的狒狒多克隆和大鼠单克隆抗独特型抗体
抗原性模仿CEA的抗体。在这个项目中,他们将
评估这些抗独特型抗体是否可以作为替代品
仓鼠体内的抗原。仓鼠之所以被选中,是因为它们是唯一
已知的非免疫缺陷动物物种,在这些物种中人类产生CEA
肿瘤可能会生长。仓鼠代表了一种独特的模型来测试是否活跃
抗独特型免疫可防止肿瘤生长。这一阶段
我的研究将为更广泛的临床前和
第二阶段的临床研究。
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract) Cancer patients
are usually tolerant to the antigens expressed on tumor cells.
Triggering an active immune response by the patients to tumor-associated
antigens represents one of the most promising prospects in cancer
therapy. In this project, the investigators propose a preclinical study
of the anti-idiotype approach to trigger an active immune response
against CEA. Certain anti-idiotypic antibodies directed against the
variable regions of antibodies specific for a given antigen can mimic
(i.e., bear the internal image of) this antigen. In several experimental
systems, immunization with anti-idiotypic antibodies elicited specific
immunity in lieu of the original antigen. Immunization with anti-
idiotype antibodies as surrogate antigens is a promising approach to
trigger immunity to tolerized antigens such as tumor antigens. They have
already generated baboon polyclonal and rat monoclonal anti-idiotype
antibodies that antigenically mimic CEA. In this project they will
assess whether these anti-idiotype antibodies can function as surrogate
antigens in hamsters. Hamsters have been chosen since they are the only
known non-immunodeficient animal species in which human CEA-producing
tumors may grow. Hamsters represent a unique model to test whether active
anti-idiotype immunization can protect against tumor growth. This Phase
I study will represent the basis for more extensive preclinical and
clinical studies in Phase II.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RADIOIMMUNOTHERAPY USING BISPECIFIC ANTIBODIES
-
批准号:6377254
-
项目类别:
-
资助金额:$25.4万
-
财政年份:1999
-
负责人:HANS J HANSEN
-
依托单位:
RADIOIMMUNOTHERAPY USING BISPECIFIC ANTIBODIES
-
批准号:6211887
-
项目类别:
-
资助金额:$44.29万
-
财政年份:1999
-
负责人:HANS J HANSEN
-
依托单位: